Sankala Group’s Zimmer Biomet ZBH Stock Holding History

Sankala Group’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-40	Closed	-$3.94K	–	647
2026 Q1	$3.94K	Hold	40	–	–	﹤0.01%	447
2025 Q4	$3.94K	Buy	+40	New	+$3.79K	﹤0.01%	465

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sankala Group's ZBH Position: Q2 2026 in Review

Sankala Group sold out of Zimmer Biomet (ZBH) in Q2 2026, closing a stake of 40 shares — an estimated $3.94K sold.

Sankala Group first reported a position in ZBH in Q4 2025 and held it in 2 quarters. The position peaked at $3.94K in Q1 2026. 911 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Sankala Group reported no remaining Zimmer Biomet position as of Q2 2026 after selling out during the quarter.
Sankala Group sold 40 Zimmer Biomet shares in Q2 2026, an estimated $3.94K.
Sankala Group first reported a position in Zimmer Biomet in Q4 2025 and held it in 2 quarters.
Sankala Group's Zimmer Biomet position peaked at $3.94K in Q1 2026.
911 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Sankala Group's 13F filing for Q2 2026, filed 18 Aug 2026.